Life Spine
Private Company
Total funding raised: $60M
Overview
Life Spine is a privately held medical device company specializing in minimally invasive spinal implants, with a core focus on its expandable interbody spacer systems. The company has a commercial portfolio targeting various spinal regions and recently secured key FDA clearances and MR Conditional status for its flagship ProLift systems. Led by a new CEO, Richard Mueller, Life Spine is positioned in the growing spinal fusion market, competing by offering technologies designed to improve lordosis restoration and reduce complications compared to static implants.
Technology Platform
Micro Invasive Expandable Solutions platform centered on expandable interbody spacer technology designed to restore lordosis, disc height, and foraminal height with reduced subsidence compared to static implants.
Funding History
3Opportunities
Risk Factors
Competitive Landscape
Life Spine competes in the crowded spinal implant market against major players like Medtronic, Stryker, NuVasive, and Globus Medical. Its differentiation is primarily through its focus on minimally invasive expandable interbody systems, competing with other specialists in this sub-segment such as SeaSpine, Alphatec, and ZimVie.